ARK Genomic Revolution ETF
ARKG
4 hedge funds and large institutions have $897K invested in ARK Genomic Revolution ETF in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
5% more capital invested
Capital invested by funds: $854K → $897K (+$43K)
1.17% more ownership
Funds ownership: 11.99% → 13.16% (+1.2%)
33% less funds holding
Funds holding: 6 → 4 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| 1 |
Jane Street
New York
|
+$103K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$16K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $776K | +$103K | +5,846 | +15% |
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $57K | – | – | – |
|
|
LTFS
3
Ladenburg Thalmann Financial Services
Miami,
Florida
| $49K | – | – | – |
|
|
HFM
4
Hartford Financial Management
Hartford,
Connecticut
| $15K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$16K | -913 | Closed |
|
|
IA
6
IFP Advisors
Tampa,
Florida
| – | -$6K | -198 | Closed |
|
ARKG Hedge Fund Activity: Q2 2016 in Review
4 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2016, worth a combined $897K — up 5% from $854K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ARKG and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $103K. The largest seller was UBS Group, exiting entirely with an estimated $16K sold.
- 4 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2016, down from 6 in Q1 2016.
- Funds reported $897K of ARK Genomic Revolution ETF stock for Q2 2016, up 5% quarter-over-quarter.
- 0 funds opened new ARK Genomic Revolution ETF positions in Q2 2016 and 2 closed out, a net change of -2 holders.
- The largest ARK Genomic Revolution ETF buyer in Q2 2016 was Jane Street, an estimated $103K added.
- The largest ARK Genomic Revolution ETF seller in Q2 2016 was UBS Group, an estimated $16K sold.
Based on aggregated 13F filings for Q2 2016.